Table 2.
Comparison matrices of model inputs for vaccines (Respondent 1).
| Comparison Matrix for Vaccines with Respect to: Availability (CR = 4.1%) | ||||||
| Vaccine | Pfizer-BioNTech | Moderna | AstraZeneca | Sinopharm | Sputnik V | Janssen |
| Pfizer-BioNTech | 1 | 1 | 1 | 1 | 3 | 1 |
| Moderna | 1 | 1 | 1 | 1 | 3 | 1 |
| AstraZeneca | 1 | 1 | 1 | 3 | 3 | 1 |
| Sinopharm | 1 | 1 | 0.333 | 1 | 3 | 0.333 |
| Sputnik V | 0.333 | 0.333 | 0.333 | 0.333 | 1 | 0.5 |
| Janssen | 1 | 1 | 1 | 3 | 2 | 1 |
| Comparison Matrix for Vaccines with Respect to: Formula (CR = 4.9%) | ||||||
| Vaccine | Pfizer-BioNTech | Moderna | AstraZeneca | Sinopharm | Sputnik V | Janssen |
| Pfizer-BioNTech | 1 | 1 | 0.333 | 0.333 | 3 | 0.333 |
| Moderna | 1 | 1 | 0.333 | 0.333 | 3 | 0.333 |
| AstraZeneca | 3 | 3 | 1 | 0.5 | 3 | 1 |
| Sinopharm | 3 | 3 | 2 | 1 | 4 | 2 |
| Sputnik V | 0.333 | 0.333 | 0.333 | 0.25 | 1 | 0.5 |
| Janssen | 3 | 3 | 1 | 0.5 | 2 | 1 |
| Comparison Matrix for Vaccines with Respect to: Efficacy (CR = 7.9%) | ||||||
| Vaccine | Pfizer-BioNTech | Moderna | AstraZeneca | Sinopharm | Sputnik V | Janssen |
| Pfizer-BioNTech | 1 | 1 | 0.5 | 4 | 5 | 0.5 |
| Moderna | 1 | 1 | 0.5 | 4 | 5 | 0.5 |
| AstraZeneca | 2 | 2 | 1 | 4 | 3 | 1 |
| Sinopharm | 0.25 | 0.25 | 0.25 | 1 | 4 | 0.333 |
| Sputnik V | 0.2 | 0.2 | 0.333 | 0.25 | 1 | 0.333 |
| Janssen | 2 | 2 | 1 | 3 | 3 | 1 |
| Comparison Matrix for Vaccines with Respect to: Side Effects (CR = 4.7%) | ||||||
| Vaccine | Pfizer-BioNTech | Moderna | AstraZeneca | Sinopharm | Sputnik V | Janssen |
| Pfizer-BioNTech | 1 | 1 | 2 | 0.25 | 3 | 3 |
| Moderna | 1 | 1 | 3 | 0.25 | 3 | 2 |
| AstraZeneca | 0.5 | 0.333 | 1 | 0.333 | 1 | 1 |
| Sinopharm | 4 | 4 | 3 | 1 | 4 | 3 |
| Sputnik V | 0.333 | 0.333 | 1 | 0.25 | 1 | 0.5 |
| Janssen | 0.333 | 0.5 | 1 | 0.333 | 2 | 1 |
| Comparison Matrix for Vaccines with Respect to: Cost (CR = 4.3%) | ||||||
| Vaccine | Pfizer-BioNTech | Moderna | AstraZeneca | Sinopharm | Sputnik V | Janssen |
| Pfizer-BioNTech | 1 | 0.333 | 0.333 | 0.2 | 0.333 | 0.333 |
| Moderna | 3 | 1 | 0.333 | 0.2 | 0.333 | 0.333 |
| AstraZeneca | 3 | 3 | 1 | 0.333 | 0.5 | 1 |
| Sinopharm | 5 | 5 | 3 | 1 | 1 | 3 |
| Sputnik V | 3 | 3 | 2 | 1 | 1 | 2 |
| Janssen | 3 | 3 | 1 | 0.333 | 0.5 | 1 |
| Comparison Matrix for Vaccines with Respect to: Host Factors (CR = 4.7%) | ||||||
| Vaccine | Pfizer-BioNTech | Moderna | AstraZeneca | Sinopharm | Sputnik V | Janssen |
| Pfizer-BioNTech | 1 | 1 | 1 | 0.5 | 0.333 | 1 |
| Moderna | 1 | 1 | 1 | 0.5 | 0.333 | 1 |
| AstraZeneca | 1 | 1 | 1 | 0.333 | 1 | 1 |
| Sinopharm | 2 | 2 | 3 | 1 | 3 | 3 |
| Sputnik V | 3 | 3 | 1 | 0.333 | 1 | 1 |
| Janssen | 1 | 1 | 1 | 0.333 | 1 | 1 |
1 = Equally important, 3 = Somewhat more important, 5 = Much more important, 7 = Very much more important, 9 = Absolutely important. The grey color indicates the selection of the respondent. The white color indicates the inverse value of the selection of the respondent. The pale blue color indicates a value of 1 (equally important) when comparing an alternative to itself.